Vaidehi Mujumdar, MD (@VeeMuj) header
Vaidehi Mujumdar, MD (@VeeMuj) profile picture
Joined July 2013
Photo by Vaidehi Mujumdar, MD (@VeeMuj)Photo by Vaidehi Mujumdar, MD (@VeeMuj)Photo by Vaidehi Mujumdar, MD (@VeeMuj)Photo by Vaidehi Mujumdar, MD (@VeeMuj)Photo by Vaidehi Mujumdar, MD (@VeeMuj)Photo by Vaidehi Mujumdar, MD (@VeeMuj)Photo by Vaidehi Mujumdar, MD (@VeeMuj)Photo by Vaidehi Mujumdar, MD (@VeeMuj)Photo by Vaidehi Mujumdar, MD (@VeeMuj)Photo by Vaidehi Mujumdar, MD (@VeeMuj)
Vaidehi Mujumdar, MD retweeted
🔥 Lighting the Flame for a World Free from HPV-Related Diseases! What a great gathering of the global HPV community in Athens, Greece, for the 38th Annual Conference of the International Papillomavirus Society! #IPVS2026 Researchers and health professionals from around the world are sharing the latest science, exchanging ideas, and working together toward a world free from HPV-related diseases. IGCS is proud to be part of the conversation. IGCS Past President Prof. Greta Dreyer and Secretary-Treasurer-Elect Prof. Hennie Botha shared their expertise on improving cervical cancer care in low- and middle-income countries, including surgical management of invasive cervical cancer and expanding access to thermal ablation for cervical precancer. And of course, we couldn't miss a chance to get everyone excited for Tokyo! With about 130 colleagues in the room, we gathered everyone for a group photo to build some excitement for IGCS 2027, November 4–6 in Tokyo, where we'll meet together with the Japan Society of Gynecologic Oncology (JSGO). A big thank you to IPVS for bringing everyone together! We love seeing these global connections in action and can't wait to welcome colleagues to Tokyo next year as IGCS celebrates 40 years! 🎉 #IPVS2026 #IGCS2027 #CervicalCancerElimination #GlobalCollaboration
3
9
552
Vaidehi Mujumdar, MD retweeted
The HPV vaccine is a powerful way to prevent cancer. Learn common facts about HPV and find out about new screening options that let some patients collect their own samples using a swab to test for high-risk HPV types linked to cervical cancer. uchicagomedicine.org/forefro…
1
7
18
2,021
Vaidehi Mujumdar, MD retweeted
A heartfelt thank you to everyone who joined us during #GynecologicCancerAwarenessMonth 💜 Your voices help spread knowledge, break stigma, and remind us of something vital: Early detection saves lives! Together, we’re stronger. 💪💜 #GOAgainstStigma #WorldGODay
3
1
3
323
Vaidehi Mujumdar, MD retweeted
Join fellow SGO members in turning commitment into action at the Race to End Women's Cancer. Together, we can raise awareness, support research, and bring hope to those affected by gynecologic cancers. 💜 Register today at Move4Her.org.#Move4Her @GYNCancer
4
5
410
Vaidehi Mujumdar, MD retweeted
🔬 Four-year follow-up from the RUBY trial adds to the growing evidence supporting frontline immunotherapy in endometrial cancer! Patients with dMMR/MSI-H primary advanced or recurrent disease continued to demonstrate durable benefit with dostarlimab + carboplatin/paclitaxel, reinforcing this regimen as a key treatment option. #GynOnc #EndometrialCancer #SGO #Immunotherapy Check it out here: tinyurl.com/35s7wayc
3
1
8
2,301
Vaidehi Mujumdar, MD retweeted
SGO supports the #WomensHealthMoonshot, a framework measuring against a $20 billion, 10-year federal investment in women’s health. Created by @SWHR, American College of Obstetricians & Gynecologists (ACOG), and @wfrcoalition, read the National Strategy: swhr.org/nationalstrategy.
2
2
2
323
Vaidehi Mujumdar, MD retweeted
Calling all early career researchers in gynecologic oncology. 📣 The IGCS Early Career Network, in partnership with GCIG, is now accepting proposals for pragmatic trials aimed at improving outcomes for women with gynecologic cancers. Don't miss this opportunity to turn your innovative ideas into impactful, globally scalable research. 🚨Deadline: July 13🚨 🔗igcs.org/ecn-gcig/
3
1
13
645
What a great research symposium with fantastic fellow and resident presentations and honored guest @WarnerHuhUAB! And of course it wouldn’t have been complete without the legacy gala with leadership from @jubileebrown @wendel_naumann and Dr. Erin Crane!
1
1
226
Vaidehi Mujumdar, MD retweeted
If you were born with ovaries, you’re at risk of ovarian cancer. Know the signs: bloating, loss of appetite, abdominal pain, frequent urination. Listen, speak up, and #AskHer. Questions can lead to early diagnosis and save lives. #WorldOvarianCancerDay
5
1
205
Vaidehi Mujumdar, MD retweeted
Michelle and I can’t wait for you to visit the Obama Presidential Center! Starting on June 19, the Center will be open to the public, and you’ll be able to check out the Museum along with public spaces like a new branch of the Chicago Public Library with a reading room, a two-acre playground, a fruit and vegetable garden, and more. Tickets available at tickets.obama.org.
22,789
25,056
1,941
252,110
35,183,457
Incredibly excited for @ASCO and @WAGO_org this year! Come find our abstracts (my co-fellow Dr. Goodwin and I) at ASCO and my oral presentation on the intersection of rural, ethnic, Medicaid related #disparities in #cervicalcancer at WAGO!
3
128
Vaidehi Mujumdar, MD retweeted
Abstract submission is closing soon for the IGCS 2026 Annual Global Meeting. Submit your research before May 4, 2026 — 11:59 PM ET to be considered for presentation in Montréal. Deadline: May 4, 2026 at 11:59 PM ET igcsmeeting.com/submit-an-ab… #IGCS2026 #GynecologicOncology #CancerResearch #MedicalConference #OncologyCommunity
1
1
228
Great to see ICI sequencing explored in other disease sites. More to come from the gyn onc space @jubileebrown @wendel_naumann
Outcomes of immune-checkpoint inhibitor rechallenge in metastatic clea... sciencedirect.com/science/ar…
281
To submit your Tumor Board click link in bio or go to ow.ly/hopU50YNJXF #WAGO2026 #WAGO
1
62
#AACR26 | Gyn Onc #MYTHIC trial (CT022) - first-in-human data for #WEE1i #zedoresertib + #PKMYT1i #lunresertib in genomically selected solid tumors (#CCNE1 amp, #FBXW7 mut, #PPP2R1A mut). These alterations drive replication stress and have NO approved targeted therapy - 24.5% of ovarian, 18.4% of uterine cancers. In resistant/refractory #ovariancancer at the lead dose: ▪️ 50% ORR, 83% DCR ▪️ 60% ORR in CCNE1-amp ▪️ 67% ctDNA molecular response rate ▪️ Responses after mirvetuximab, T-DXd, T-DM1 ▪️ No myelosuppression. Zero discontinuations. First clinical proof-of-concept for synthetic lethality in this space. FDA Fast Track granted. Presented by @TimothyYap @DebiopharmNews @RepareRx #GynOnc #PrecisionOncology #AACR26
1
15
43
3,666
Vaidehi Mujumdar, MD retweeted
Please join us in congratulating the 2026 SGO Board! We are proud to celebrate this exceptional group of leaders whose service will help shape the future of gynecologic oncology and improve outcomes for patients everywhere. #SGOAM26 #GynOnc
3
1
11
727
Vaidehi Mujumdar, MD retweeted
💫 #SGOAM2026 Highlight @DGlaucomflecken as an invited speaker He reflected upon his own cancer experience & cardiac arrest, and noted how this impacted his partner, @LGlaucomflecken, who is a co-survivor. Oftentimes in our specialty of #oncology, we focus our conversations on the patient - their goals, treatment wishes, expectations. He reminded us that amongst all this essential dialogue, we should not overlook the person sitting just beside them - the wife, husband, partner, caregiver - the co-survivor. Taking a moment to simply ask “how are you doing?” is more than a courtesy - it is an act of recognition. It acknowledges that #cancer does not happen in isolation, but within a network of relationships that also deserve care, compassion, and support. By intentionally including co-survivors in our conversations, validating their experiences, and guiding them to resources when needed, we reinforce a more human-centered approach to cancer care. @DGlaucomflecken also talked about his approach to humor in medicine. His popular skits have gained a lot of attention online and his satirical themes resonates with the healthcare audience, not just because they’re funny but because they offer a rare space to process the realities we often experience. He even debuted a new skit just for @SGO_org! Have you ever heard of the #LACCTrial? It is a landmark trial within the field of #GynOncology that changed our surgical approach to early-stage #cervicalcancer. It showed #minimallyinvasive #radicalhysterectomy for early-stage cervical cancer was associated with a worse disease-free survival & overall survival, compared to open surgery, thus shifting the standard of care toward open approaches. His approach to this topic has everyone laughing! What are your thoughts on his latest skit? @pedroramirezMD @leitaomd @IJGConline @IGCSociety @gynoncjnls @karenluMD @matthewapowell @AngelesSecord @amandanfader @TeamEndo_MSK @GreggNelsonERAS @RSalaniMD @BPothuri @BillzamMD @Bhandoria @nicoleflemingmd @agz_eriksson @JCohenMD @MAvilaMD @VeeMuj #gyncsm #SGO2026 #hysterectomy #survivor #gyncancer @OncBrothers @OncLive
6
17
948
Vaidehi Mujumdar, MD retweeted
Long-term data from the #PITVIN trial 📊 ✅ Imiquimod and surgery work for vulvar #HSIL ✅ 1 in 3 women 🚺 still face recurrence within 5-y ✅ Better risk stratification and follow-up are needed 🔎💊 💡 bit.ly/4vG0ZIW @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @luribero26 @beatesarta @AlwynDO @PeppeParisi_ @ilkerselcukmd @VinTarantino @NSeminario27498 @dranushak88
1
5
16
1,346
Vaidehi Mujumdar, MD retweeted
Very impactful data in the genetics session this am #SGOAM2026, estrogen replacement is safe in premenopausal BRCA mutation carriers and they should be offered this after risk reducing surgery. Dr. Blank highlighted the need to lead the charge in prevention and counseling. @SGO_org @RiosDoriaMD
3
12
20
2,045
Vaidehi Mujumdar, MD retweeted
Honored to present results of GOG 3039 Abemaciclib + Letrozole in advanced or recurrent endometrioid endometrial cancer. We observed median PFS of 9.5mo, OS not reached, & greatest benefit in chemo-naive pts! @GOG @SGO_org @EliLillyandCo
2
6
14
685